Specifically, this order places FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols in schedule V."
Pepsi doesn't make up the entire beverage market. This allows new companies to get into a niche market. According to one estimate, CBD market will grow to $22 billion dollars by 2022. Huge opportunities, if you ask me.